MedTrace Logo

Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication

NCT02774811 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-05-02

No results posted yet for this study

Summary

Multi-centre randomised controlled trial of selective laser trabeculoplasty compared with prostaglandin analogue therapy as primary treatment for high tension open angle glaucoma.

Participating centres are:

Institute of Ophthalmology, UCL, London, UK McCord Hospital, Durban, South Africa Innovation Eye Centre, Kisii, Kenya

Conditions

Interventions

DRUG

Prostaglandin analogue

Topical therapy

PROCEDURE

Selective laser trabeculoplasy

Laser therapy into drainage angle

DEVICE

laser

Sponsors & Collaborators

  • University of KwaZulu

    collaborator OTHER

  • Kisii Eye Hospital Kisii Kenya

    collaborator UNKNOWN

  • University College, London

    lead OTHER

Principal Investigators

  • Ian Murdoch, MD FRCOphth · UCL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02774811 on ClinicalTrials.gov